Compound 2375
Identifiers
- Common name: NV06
- Canonical SMILES:
CCN(CC)CCCNC(=O)Cn1nc(C)n2c(cc3c(F)cccc23)c1=O
- IUPAC name:
N-[3-(diethylamino)propyl]-2-{9-fluoro-4-methyl-1-oxo-1H,2H-[1,2,4]triazino[4,5-a]indol-2-yl}acetamide
- InChi:
InChI=1S/C20H26FN5O2/c1-4-24(5-2)11-7-10-22-19(27)13-25-20(28)18-12-15-16(21)8-6-9-17(15)26(18)14(3)23-25/h6,8-9,12H,4-5,7,10-11,13H2,1-3H3,(H,22,27)
- InChiKey:
VMWVNBGFGFTYOQ-UHFFFAOYSA-N
External links
![]() 168317719 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
UHRF1 / H3 | 4.26 | breast cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 387.21 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 0.83 | |||
TPSA | 71.14 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1177/2472555218766278 | NV06 | UHRF1 Q96T88 |
H32 Q71DI3 |
Biochemical assay | Fluorescence Polarization | pKd (dissociation constant, -log10) | 4.26 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4444 | CCX-354 | DB12963 | |
0.4293 | Trazodone | DB00656 | |
0.4215 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4124 | AZD-1386 | DB15333 | |
0.4118 | Avadomide | DB14857 | |
0.3952 | Alatrofloxacin | DB09335 | |
0.3919 | (2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE | DB07135 | |
0.3865 | Danofloxacin | DB11393 | |
0.3853 | Moxifloxacin | DB00218 | |
0.3850 | 1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide | DB06909 | |
0.3846 | Futibatinib | DB15149 | |
0.3835 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.3831 | Rabeximod | DB05772 | |
0.3827 | Ibrutinib | DB09053 | |
0.3822 | Pradofloxacin | DB11453 |